<i>In-silico</i> probing of AML related RUNX1 cancer-associated missense mutations: Predicted relationships to DNA binding and drug interactions.

In-silico probing of AML related RUNX1 cancer-associated missense mutations: Predicted relationships to DNA binding and drug interactions.

Ullah, Hanif; Zhang, Baoyun; Sharma, Narendra Kumar; McCrea, Pierre D; Srivastava, Yogesh.

Afiliação

Ullah H; Guangxi Key Laboratory for Genomics and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomics and Personalized Medicine, Guangxi Medical University, Nanning, China.
Zhang B; Key Laboratory of Regenerative Biology, South China Institute for Stem Cell Biology and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
Sharma NK; University of Chinese Academy of Sciences, Beijing, China.
McCrea PD; Key Laboratory of Regenerative Biology, South China Institute for Stem Cell Biology and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
Srivastava Y; University of Chinese Academy of Sciences, Beijing, China.

Front Mol Biosci ; 9: 981020, 2022.

Article em En | MEDLINE | ID: mdl-36090034